Skip to main content
. 2014 Sep 10;9(9):e107507. doi: 10.1371/journal.pone.0107507

Figure 4. Overall survival and recurrence-free survival are shown for patients with high tumor invasiveness (A) and low tumor invasiveness (B).

Figure 4

Kaplan-Meier survival estimates and log-rank tests were used to analyze the association between HSP60 status and overall survival or recurrence-free survival in patients with low invasiveness (low MMP-9; n = 118) or high invasiveness (high MMP-9; n = 105).